Temozolomide in the treatment of children with newly diagnosed diffuse intrinsic pontine gliomas: a report from the Children's Oncology Group. - Wikidata - wikimedia - TriplyDB

Temozolomide in the treatment of children with newly diagnosed diffuse intrinsic pontine gliomas: a report from the Children's Oncology Group.

Temozolomide in the treatment of children with newly diagnosed diffuse intrinsic pontine gliomas: a report from the Children's Oncology Group.

http://www.wikidata.org/entity/Q34722864

about

DIPG in Children - What Can We Learn from the Past?Molecular Biology in Pediatric High-Grade Glioma: Impact on Prognosis and Treatment In vitro drug response and efflux transporters associated with drug resistance in pediatric high grade glioma and diffuse intrinsic pontine glioma Diffuse Intrinsic Pontine Glioma: New Pathophysiological Insights and Emerging Therapeutic Targets Clinico-radiologic characteristics of long-term survivors of diffuse intrinsic pontine glioma.Clinical management and outcome of histologically verified adult brainstem gliomas in Switzerland: a retrospective analysis of 21 patients.Survival prediction model of children with diffuse intrinsic pontine glioma based on clinical and radiological criteria The under reporting of recruitment strategies in research with children with life-threatening illnesses: A systematic review Radiotherapy with concurrent and adjuvant temozolomide in children with newly diagnosed diffuse intrinsic pontine glioma.A pediatric phase 1 trial of vorinostat and temozolomide in relapsed or refractory primary brain or spinal cord tumors: a Children's Oncology Group phase 1 consortium study Pediatric high-grade glioma: biologically and clinically in need of new thinking Antigen-specific immune responses and clinical outcome after vaccination with glioma-associated antigen peptides and polyinosinic-polycytidylic acid stabilized by lysine and carboxymethylcellulose in children with newly diagnosed malignant brainstem Childhood brain tumors: epidemiology, current management and future directions.Children's Oncology Group's 2013 blueprint for research: central nervous system tumors.Differences in molecular genetics between pediatric and adult malignant astrocytomas: age matters.Management of diffuse pontine gliomas in children: recent developments.Phase 2 study of safety and efficacy of nimotuzumab in pediatric patients with progressive diffuse intrinsic pontine glioma.Disrupting the CD47-SIRPα anti-phagocytic axis by a humanized anti-CD47 antibody is an efficacious treatment for malignant pediatric brain tumors.Initial testing (stage 1) of temozolomide by the pediatric preclinical testing program Brainstem glioma: a review.Effect of time from diagnosis to start of radiotherapy on children with diffuse intrinsic pontine glioma Pediatric Brain Tumors: Innovative Genomic Information Is Transforming the Diagnostic and Clinical Landscape.A phase 2 study of pegylated interferon α-2b (PEG-Intron(®)) in children with diffuse intrinsic pontine glioma.Treatment outcomes in black and white children with cancer: results from the SEER database and St Jude Children's Research Hospital, 1992 through 2007 Disrupting NOTCH Slows Diffuse Intrinsic Pontine Glioma Growth, Enhances Radiation Sensitivity, and Shows Combinatorial Efficacy With Bromodomain Inhibition Molecular profiling of childhood cancer: Biomarkers and novel therapies Development of a DIPG Orthotopic Model in Mice Using an Implantable Guide-Screw System.A phase II study of O6-benzylguanine and temozolomide in pediatric patients with recurrent or progressive high-grade gliomas and brainstem gliomas: a Pediatric Brain Tumor Consortium study.Tumor location, but not H3.3K27M, significantly influences the blood-brain-barrier permeability in a genetic mouse model of pediatric high-grade glioma Motexafin-gadolinium and involved field radiation therapy for intrinsic pontine glioma of childhood: a children's oncology group phase 2 study.Diffuse intrinsic pontine glioma: poised for progress.Targeted therapy for BRAFV600E malignant astrocytoma.Pediatric gliomas as neurodevelopmental disorders Phase I trial of capecitabine rapidly disintegrating tablets and concomitant radiation therapy in children with newly diagnosed brainstem gliomas and high-grade gliomas.Pediatric Brain Tumors: Current Knowledge and Therapeutic Opportunities Diffuse intrinsic pontine glioma treated with prolonged temozolomide and radiotherapy--results of a United Kingdom phase II trial (CNS 2007 04).Re-Examining the Need for Tissue Diagnosis in Pediatric Diffuse Intrinsic Pontine Gliomas: A Review.Genomic Insights into Diffuse Intrinsic Pontine Glioma.Treatment of high-grade glioma in children and adolescents.Paediatric and adult malignant glioma: close relatives or distant cousins?

P2860

Q26777843-BF651FE4-D291-4ED9-8C5C-897D989F138E Q26785952-7030CFFA-65F1-4E89-A78C-81B12D796B9B Q28487205-88348F67-2953-48A3-B700-31E0EA6E07BE Q30251385-AD14DA8D-0915-4C25-9875-1BF30C318E11 Q30652433-22C9FBCC-DC56-4ED8-BC43-84F416A0CF58 Q30801851-EBCA6244-62D8-4AA2-8553-3C7D55A1C978 Q30829348-A7C7905C-AD47-44C9-B902-3C60B627DF88 Q30847046-76E24D6B-AE47-4E14-819F-DAC281399441 Q33396801-34BDD039-CE32-4050-8B88-F58D136DC8C0 Q33406813-482B891E-A2F4-41E0-8894-812A0D13D97E Q33777868-FCFB575A-DC9F-41CE-B832-C4920544287D Q33796170-C67F270F-372C-4B78-8987-D0877BF8B651 Q33970971-6409D916-D764-4815-9A09-0813318527C7 Q34285237-18596BB1-B0BE-45D6-9C9E-494231F90C00 Q34286305-F6F58274-EFEC-4D23-A316-B681DC25E2C7 Q34347540-FCD723E1-8291-4DEE-9569-D472B5499ECB Q34359662-D2846D1A-5DAA-497F-A1E9-7B7B42E27799 Q34553348-E1CB3F68-EE9F-4304-913F-F6D6C5D3E433 Q34571940-ECD43226-45E6-464D-9357-4E6975D9E932 Q34628180-2701DA25-765C-4152-B406-FB301D85EB20 Q35230772-1916DC49-828F-465E-A541-B77F83CAD6DE Q35754390-6CACEFA2-5D34-426B-B176-98785ACC0C04 Q35791274-38BE574C-EC44-4151-BC5D-D1FAC3DD0BEC Q36058482-F5DC2D45-0BE4-4B97-95D5-4D55EF9FC03B Q36130555-C9F142DE-4B47-488A-B392-1A57B114481E Q36250783-4CE15635-8A7A-4FB8-9D6B-5A63535ACED4 Q36255670-862C1094-3E2F-4C21-9463-6936C3CFDEEE Q36455403-77B3F843-44E5-4962-88A2-E4E529D63321 Q36484037-66E361FC-4251-4D1D-A7B4-2A4CC38FB510 Q36485991-B83CA510-C0F1-4C84-8DCA-6C2321D1418C Q36492719-10BE2D92-1A35-44AE-850A-39F6E63A6520 Q36800148-002F5E7B-0AA0-41C9-A347-D44090B9549A Q36803476-343EAEC9-49EC-4EC6-8671-572B704A486E Q36865982-CD0862B0-8985-44A4-94D7-79696E984DAF Q37213305-E2A1D630-5D6F-450D-81A5-08A6D78D49AB Q37369556-60E17494-BA07-4A5C-AF10-5F71D697CBEB Q37668034-B07878DF-A1F1-4B29-A725-66A75D709A02 Q37723508-C25F7CC7-AE73-4BE4-8722-B2B02BB958D4 Q37904503-7478A06E-F88E-4E54-9C06-7FD1B98B4934 Q38013990-DA4B7D03-B5E4-4D92-ADDC-477E50EAF7C8

P2860

Temozolomide in the treatment of children with newly diagnosed diffuse intrinsic pontine gliomas: a report from the Children's Oncology Group.

http://www.wikidata.org/entity/Q34722864

description

2011 nî lūn-bûn

@nan

2011 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Temozolomide in the treatment ...... the Children's Oncology Group.

@ast

Temozolomide in the treatment ...... the Children's Oncology Group.

@en

Temozolomide in the treatment ...... the Children's Oncology Group.

@nl

type

label

Temozolomide in the treatment ...... the Children's Oncology Group.

@ast

Temozolomide in the treatment ...... the Children's Oncology Group.

@en

Temozolomide in the treatment ...... the Children's Oncology Group.

@nl

prefLabel

Temozolomide in the treatment ...... the Children's Oncology Group.

@ast

Temozolomide in the treatment ...... the Children's Oncology Group.

@en

Temozolomide in the treatment ...... the Children's Oncology Group.

@nl

P1433

Q34722864-8C8AE142-35DE-4CD0-93E2-00AE3F5A44FC

P1476

Q34722864-CFD5D09E-73EC-40C0-A86B-03DDCF0DA9D9

P2093

Q34722864-0011BF6C-CAF7-4FC0-81DE-D1E2EBBDC8E2

Q34722864-32208B21-2DEF-4FA1-AFE4-20D0D7283144

Q34722864-C4024AAF-BC03-42C9-9B8D-5211EDAD3EBC

Q34722864-D7E3B95D-66B5-4FFD-80D7-38F5DADFF82F

Q34722864-EE716987-DD28-41BE-9705-9B730F50009B

Q34722864-FF509DC1-00DB-4227-AC24-568EE0D6455B

P2860

Q34722864-06C63D7D-020E-41E8-8659-46DB4768A077

Q34722864-0AE6B310-BCF3-4BB2-88CB-87B96BE88CC9

Q34722864-0B417DAE-CA7D-454A-86A3-F9DE81E4B227

Q34722864-0BDA56C2-BD5B-4AAD-BC86-4683A57006E8

Q34722864-1174292C-102E-4119-A515-3179BBB64F43

Q34722864-136A218C-B7EE-4B04-AF79-215FFBDA2EAF

Q34722864-16092EEB-2BDC-4259-A9FA-936B2B1EDF0B

Q34722864-200C5628-8F71-4CB5-A4AE-309E863DC392

Q34722864-38D8EC97-884A-44BD-BDB6-C02E5C43FC8B

Q34722864-3CEF4D58-B29E-4CE5-971E-D56BCC234E93

P304

Q34722864-970663AA-6A4D-48D1-9176-FC13BD5C5792

P31

Q34722864-136CB7BA-8ACF-4E65-972D-DDD3283801B7

P356

Q34722864-ED531F7F-E77D-40F3-8CAE-3363E8DCD2AD

P433

Q34722864-F57724C8-5D98-4975-A890-904BB9AEE447

P478

Q34722864-6CD937C2-AEF8-41E3-BDB9-320C6CB52A03

P50

Q34722864-4C1A9D3B-BECF-4347-A012-F43E91BA0857

P577

Q34722864-E0E656EC-8C50-4831-B3DB-8E7B1C285AA5

P5875

Q34722864-86770A39-55DD-4897-9C75-2B367A921EEE

P698

Q34722864-6221E5F9-823B-4FA4-864B-2CC6451225C1

P921

Q34722864-614D6A90-20CD-4EDE-917B-91C6AEB1B7AE

P932

Q34722864-8BB19D4B-EF60-4D7F-BC82-A0AA0FA51234

P356

P1433

P1476

Temozolomide in the treatment ...... the Children's Oncology Group.

@en

P2093

Emiko J Holmes

http://www.w3.org/2001/XMLSchema#string

Ian F Pollack

http://www.w3.org/2001/XMLSchema#string

Kenneth J Cohen

http://www.w3.org/2001/XMLSchema#string

Richard L Heideman

http://www.w3.org/2001/XMLSchema#string

Robert S Lavey

http://www.w3.org/2001/XMLSchema#string

Tianni Zhou

http://www.w3.org/2001/XMLSchema#string

P2860

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

Diffuse brain stem glioma. A review of stereotactic biopsies.

Diffuse brainstem glioma in children: critical review of clinical trials.

Advances toward an understanding of brainstem gliomas.

Magnetic resonance imaging compared with biopsy in the diagnosis of brainstem diseases of childhood: a multicenter review.

A phase I/II study of carboplatin combined with hyperfractionated radiotherapy for brainstem gliomas.

Role of temozolomide after radiotherapy for newly diagnosed diffuse brainstem glioma in children: results of a multiinstitutional study (SJHG-98).

Brainstem gliomas in children and adults.

A phase II study of the farnesyl transferase inhibitor, tipifarnib, in children with recurrent or progressive high-grade glioma, medulloblastoma/primitive neuroectodermal tumor, or brainstem glioma: a Children's Oncology Group study.

Phase I trial of single-dose temozolomide and continuous administration of o6-benzylguanine in children with brain tumors: a pediatric brain tumor consortium report.

P304

410-416

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/NEUONC/NOQ205

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

13

http://www.w3.org/2001/XMLSchema#string

P50

P577

2011-02-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

49966558

http://www.w3.org/2001/XMLSchema#string

P698

21345842

http://www.w3.org/2001/XMLSchema#string

P921

diffuse intrinsic pontine glioma

P932

3064697

http://www.w3.org/2001/XMLSchema#string